Adenosine Monophosphate: Clinical Trials

25 trials of Adenosine Monophosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 3 unknown, 2 recruiting, 2 terminated. 10 Not applicable, 6 Phase 4, 4 Phase 1, 3 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 7, Unknown 2, Recruiting 1
Phase 46Completed 4, Recruiting 1, Unknown 1
Phase 14Completed 2, Terminated 2
Phase 33Completed 3
Early Phase 11Completed 1
Phase 21Completed 1

Follow Adenosine Monophosphate: new trials by email Literature Review of Adenosine Monophosphate trials Research Report on Adenosine Monophosphate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture
Ankle Muscle Power (AMP) program, Standard of Care - Ankle Fractures
Not applicableRecruitingBrian W. Noehren602025-11-132025-12-02
Quantitative and Qualitative Research for "mHealth Program to Support People Living With HIV Across the HIV Care Continuum"
Amp - HIV Infections
Not applicableUnknownSentient Research3002024-04-292024-04-24
AWARE: Management of ADHD in Autism Spectrum Disorder
Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant. - ADHD, Autism Spectrum Disorder
Phase 4RecruitingDaniel Coury5002023-10-012026-10-22
The Prophylactic Role of Tranexamic Acid in High Risk Pregnant Women Undergoing Elective Cesarean Section in Prevention of Postpartum Hemorrhage
Tranexamic acid (Kapron, Amoun Pharmaceuticals SAE, Egypt. 5ml Amp, 100mg /1ml) - High Risk Pregnant Women Undergoing Elective Cesarean Section
Phase 4CompletedCairo University1562022-07-032023-02-21
Evaluation of Clinical and Radiographic Outcomes of Meniscal Lesion Treatment Using Collagen Scaffolds (CMI)
Arthroscopy & saline irrigation alone - Meniscal Degeneration, Osteoarthritis of Knee
CompletedIstituto Ortopedico Rizzoli602020-11-292024-09-19
Topical Vancomycin Over Sternal Edge in Cardiac Surgery
Vancomycin Hydrochloride, Normal Saline - Sternal Wound Infection
Phase 4CompletedNational Cheng-Kung University Hospital3602020-07-012025-04-08
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
Adenosine Triphosphate, Acetylcholine, Sodium Nitroprusside - Receptor Blockade
Early Phase 1CompletedColorado State University92019-02-072021-07-27
Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy
No use of antimicrobial prophylaxis, Use of antimicrobial prophylaxis - Gastric Cancer, Complication of Surgical Procedure
Not applicableCompletedKorean South West East Gastric Surgery Group2602018-12-272022-04-06
Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment
Long luteal phase GnRH agonist protocol, Gonadotropins - Invitro Fertilization
Not applicableUnknownCairo University1002018-09-012018-09-26
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
methacholine, adenosine monophosphate, leukotriene D4 - Asthma
Phase 4UnknownZhujiang Hospital802015-04-012015-10-16
Individual Differences in the Response to Drugs
THC, AMP, ALC - Healthy
Not applicableCompletedUniversity of Chicago282013-07-012016-11-29
Attention Training for Childhood Obsessive Compulsive Disorder
Attention Modification Program, Attention Control Condition - Obsessive Compulsive Disorder
Not applicableCompletedUniversity of California, Los Angeles472013-04-012017-01-16
Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series
Attention Modification Program - Obsessive Compulsive Disorder
Phase 1CompletedUniversity of California, Los Angeles62012-11-012017-01-16
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
MMRV (AMP), MMRV (2006 process) - Measles, Mumps
Phase 3CompletedMerck Sharp & Dohme LLC14122012-06-052018-10-31
Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)
Zoster Vaccine, Live (AMP), Zoster Vaccine, Live - Herpes Zoster, Shingles
Phase 3CompletedMerck Sharp & Dohme LLC4982012-04-012017-04-12
Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
Fludarabine, Cyclophosphamide, IL-12 & Anti-NY ESO1 TCR PBL - Metastatic Cancer, Metastatic Melanoma
Phase 1TerminatedNational Cancer Institute (NCI)22011-10-062019-01-08
Intelligent Control Approach to Anemia Management
ESA Dose Adjustment per standard Anemia Management Protocol, ESA Dose Adjustment per "Smart Anemia Manager" Algorithm - End-Stage Renal Disease
Not applicableCompletedUniversity of Louisville622011-04-012017-12-13
The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism
Testogel 50 mg transdermal gel, Testosterone 250mg injection - Hypogonadotrophic Hypogonadism
Phase 4CompletedGulhane School of Medicine1062008-08-012020-07-22
Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy
Testosterone 250mg injection, Testosteron 50 mg transdermal gel - Hypogonadotrophic Hypogonadism
Phase 4CompletedGulhane School of Medicine1302008-08-012014-06-24
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Liver Biopsy, Peginterferon & Ribavirin for Hepatitis C, Pre-treatment Ribavirin - Hepatitis C, Chronic
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)812008-07-112019-12-17

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Asthma (3)  ·  HIV Infections (2)  ·  Hypogonadism (2)  ·  Inflammation (2)  ·  Insulin Resistance (2)  ·  Obsessive-Compulsive Disorder (2)  ·  Ankle Fractures (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Chickenpox (1)  ·  Generalized Anxiety Disorder (1)  ·  Hepatitis C (1)  ·  Hepatitis C, Chronic (1)  ·  Herpes Zoster (1)

Sponsors

Cairo University (2)  ·  Gulhane School of Medicine (2)  ·  Merck Sharp & Dohme LLC (2)  ·  University of California, Los Angeles (2)  ·  Brian W. Noehren (1)  ·  Colorado State University (1)  ·  Daniel Coury (1)  ·  Imperial College London (1)  ·  Istituto Ortopedico Rizzoli (1)  ·  Korean South West East Gastric Surgery Group (1)  ·  National Cancer Institute (NCI) (1)  ·  National Cheng-Kung University Hospital (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  San Diego State University (1)

Countries

United States (13)  ·  Egypt (2)  ·  Turkey (Türkiye) (2)  ·  Canada (1)  ·  China (1)  ·  Italy (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

John Piacentini, PhD (2)  ·  Susanna Chang, PhD (2)  ·  Adam E Gaweda, Ph.D. (1)  ·  Ann J. Melvin, MD (1)  ·  Ayman Hany, MD (1)  ·  Daniel Coury, MD (1)  ·  David C Shelledy, PhD (1)  ·  Donna D. Gardner, MSHP (1)  ·  Frank Dinenno, PhD (1)  ·  Harriet de Wit, PhD (1)  ·  Huizhen Fan, Doctor (1)  ·  Italo Biaggioni, M.D. (1)  ·  James McCraken, MD (1)  ·  Jay I Peters, MD (1)

Results publications

PMID 21288774, PMID 23396509, PMID 25590209, PMID 26513587, PMID 26733671, PMID 27149048, PMID 29638206, PMID 31376708, PMID 37781954

NIH funding

R34MH095885 (2), K25DK072085 (1), R01MH087623 (1)